TABLE 1.
New cases, age-standardized incidence rates and predicted five-year relative survival ratio (RSR) for esophageal cancer according to anatomical location, morphology, sex and age in Canada, 2004 to 2006
| New cases, n | Age-standardized rate, per 100,000 | Five-year RSR* % (95% CI) | |
|---|---|---|---|
| All esophageal cancers | 4388 | 3.73 | 13 (12–15) |
| Sex | |||
| Male | 3233 | 6.09 | 13 (11–14) |
| Female | 1155 | 1.72 | 15 (13–18) |
| Location | |||
| Upper esophagus | 267 | 0.23 | 12 (8–17) |
| Middle esophagus | 724 | 0.62 | 13 (10–16) |
| Lower esophagus | 2199 | 1.88 | 14 (12–15) |
| Not specified as upper, middle or lower† | 1198 | 0.20 | 13 (11–16) |
| Morphology | |||
| Squamous cell carcinoma | 1567 | 1.35 | 14 (12–16) |
| Adenocarcinoma | 2201 | 1.87 | 14 (12–15) |
| Lower esophageal adenocarcinoma | 1563 | 1.33 | 14 (12–16) |
| All other adenocarcinoma | 638 | 0.54 | 12 (9–16) |
| Other specified and unspecified types | 620 | 0.10 | 9 (6–12) |
| Age‡, years | |||
| 15–44 | 108 | 0.23 | 18 (12–26) |
| 45–54 | 471 | 3.12 | 16 (12–20) |
| 55–64 | 1031 | 9.94 | 16 (13–18) |
| 65–74 | 1235 | 18.17 | 14 (12–16) |
| 75–99 | 1543 | 25.83 | 10 (8–12) |
*
Excludes cases diagnosed in the province of Quebec;
†
Includes cancers classified as cervical (76 cases), thoracic (59 cases), abdominal (16 cases), overlapping across subsites (145 cases) or unspecified with respect to location (902 cases);
‡
No new cases observed among individuals <15 years of age. Data adapted from reference 49